Pallardy, Marc

Carcinogenicity of Perfluorooctanoic Acid and Perfluorooctanesulfonic Acid

Zahm, S., Bonde, J. P., Chiu, W. A., Hoppin, J., Kanno, J., Abdallah, M., Blystone, C. R., Calkins, M. M., Dong, G.-H., Dorman, D. C., et al. (2024) · The Lancet Oncology

Per- and polyfluoroalkyl substances researchCarcinogens and Genotoxicity Assessment

Cited by 387

GILZ expression in human dendritic cells redirects their maturation and prevents antigen-specific T lymphocyte response

Cohen, N., Mouly, E., Hamdi, H., Maillot, M.-C., Pallardy, M., Godot, V., Capel, F., Balian, A., Naveau, S., Galanaud, P., et al. (2006) · Blood

Immunotherapy and Immune ResponsesT-cell and B-cell Immunology

Cited by 170

Response to biologic drugs in patients with rheumatoid arthritis and antidrug antibodies

Bitoun, S., Hässler, S., Ternant, D., Szely, N., Gleizes, A., Richez, C., Soubrier, M., Avouac, J., Brocq, O., Sellam, J., et al. (2023) · JAMA Network Open

Rheumatoid Arthritis Research and TherapiesBiosimilars and Bioanalytical Methods

Cited by 43

Machine learning predicts response to TNF inhibitors in rheumatoid arthritis: results on the ESPOIR and ABIRISK cohorts

Bouget, V., Duquesne, J., Hassler, S., Cournède, P.-H., Fautrel, B., Guillemin, F., Pallardy, M., Broët, P., Mariette, X., & Bitoun, S. (2022) · RMD Open

Rheumatoid Arthritis Research and TherapiesAutoimmune and Inflammatory Disorders Research

Cited by 29